Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

A new method using fat tissue cells may help treat hair loss.

New methods can diagnose hair loss by examining the scalp and can treat it with a mix of oral and topical medications, along with cosmetic procedures like hair transplants.

Artemis dysfunction might cause hair loss through telomere shortening.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed for hair growth.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed for hair growth.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed to grow hair.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.

Minoxidil, originally a blood pressure medication, is effective in treating hair loss in men and women, with different strengths recommended for each.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

Aryl hydrocarbon receptor overexpression found in miniaturized hair follicles in female hair loss.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Normal hair thickness varies by scalp area and a mix of hair thicknesses is typical in healthy individuals.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

3D-printed membranes with smart sensors can greatly improve tissue healing and have many medical applications.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Minoxidil and finasteride are key treatments for hair loss.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Senescent alopecia is a type of hair loss that occurs after age 50, not caused by genetics, and involves a gradual thinning of hair without significant inflammation.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.